ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,966 | -18.4% | 24,214 | +0.4% | 0.00% | – |
| Q2 2023 | $161,784 | -20.5% | 24,111 | +4.6% | 0.00% | -100.0% |
| Q1 2023 | $203,540 | +1.8% | 23,051 | -11.9% | 0.00% | 0.0% |
| Q4 2022 | $199,969 | +15.6% | 26,174 | +7.7% | 0.00% | 0.0% |
| Q3 2022 | $173,000 | -9.9% | 24,310 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $192,000 | -5.4% | 23,601 | +61.3% | 0.00% | – |
| Q1 2022 | $203,000 | -63.6% | 14,635 | -26.4% | 0.00% | -100.0% |
| Q4 2021 | $558,000 | -45.4% | 19,874 | -33.9% | 0.00% | -66.7% |
| Q3 2021 | $1,022,000 | -0.8% | 30,070 | +19.3% | 0.00% | 0.0% |
| Q2 2021 | $1,030,000 | +32.9% | 25,211 | +30.9% | 0.00% | +50.0% |
| Q1 2021 | $775,000 | -37.9% | 19,256 | -8.8% | 0.00% | -60.0% |
| Q4 2020 | $1,248,000 | +17.3% | 21,107 | -3.5% | 0.01% | 0.0% |
| Q3 2020 | $1,064,000 | +8.5% | 21,883 | +7.9% | 0.01% | 0.0% |
| Q2 2020 | $981,000 | +106.1% | 20,274 | +18.3% | 0.01% | +66.7% |
| Q1 2020 | $476,000 | -40.8% | 17,137 | -36.3% | 0.00% | -25.0% |
| Q4 2019 | $804,000 | – | 26,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |